vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and CuriosityStream Inc. (CURI). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $19.2M, roughly 1.1× CuriosityStream Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -373.3%, a 353.6% gap on every dollar of revenue. CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.
AUTL vs CURI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $19.2M |
| Net Profit | $-79.1M | $-3.8M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | -17.6% |
| Net Margin | -373.3% | -19.7% |
| Revenue YoY | — | 35.8% |
| Net Profit YoY | 3.6% | -34.6% |
| EPS (diluted) | $-0.30 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $19.2M | ||
| Q3 25 | $21.2M | $18.4M | ||
| Q2 25 | $20.9M | $19.0M | ||
| Q1 25 | $9.0M | $15.1M | ||
| Q4 24 | — | $14.1M | ||
| Q3 24 | $0 | $12.6M | ||
| Q2 24 | $0 | $12.4M | ||
| Q1 24 | $10.1M | $12.0M |
| Q4 25 | — | $-3.8M | ||
| Q3 25 | $-79.1M | $-3.7M | ||
| Q2 25 | $-47.9M | $784.0K | ||
| Q1 25 | $-70.2M | $319.0K | ||
| Q4 24 | — | $-2.8M | ||
| Q3 24 | $-82.1M | $-3.1M | ||
| Q2 24 | $-58.3M | $-2.0M | ||
| Q1 24 | $-52.7M | $-5.0M |
| Q4 25 | — | -17.6% | ||
| Q3 25 | -337.9% | -24.5% | ||
| Q2 25 | -292.6% | 2.5% | ||
| Q1 25 | -726.3% | 0.5% | ||
| Q4 24 | — | -27.4% | ||
| Q3 24 | — | -25.8% | ||
| Q2 24 | — | -20.6% | ||
| Q1 24 | -384.1% | -30.4% |
| Q4 25 | — | -19.7% | ||
| Q3 25 | -373.3% | -20.4% | ||
| Q2 25 | -229.0% | 4.1% | ||
| Q1 25 | -781.1% | 2.1% | ||
| Q4 24 | — | -19.9% | ||
| Q3 24 | — | -24.3% | ||
| Q2 24 | — | -16.4% | ||
| Q1 24 | -522.1% | -42.0% |
| Q4 25 | — | $-0.07 | ||
| Q3 25 | $-0.30 | $-0.06 | ||
| Q2 25 | $-0.18 | $0.01 | ||
| Q1 25 | $-0.26 | $0.01 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | $-0.31 | $-0.06 | ||
| Q2 24 | $-0.22 | $-0.04 | ||
| Q1 24 | $-0.24 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $27.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $41.5M |
| Total Assets | $661.9M | $75.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $27.3M | ||
| Q3 25 | $86.1M | $27.8M | ||
| Q2 25 | $123.8M | $28.1M | ||
| Q1 25 | $95.8M | $33.4M | ||
| Q4 24 | — | $32.1M | ||
| Q3 24 | $657.1M | $33.2M | ||
| Q2 24 | $705.9M | $39.5M | ||
| Q1 24 | $758.5M | $38.8M |
| Q4 25 | — | $41.5M | ||
| Q3 25 | $265.5M | $47.2M | ||
| Q2 25 | $346.5M | $49.8M | ||
| Q1 25 | $371.1M | $58.1M | ||
| Q4 24 | — | $57.8M | ||
| Q3 24 | $477.0M | $62.2M | ||
| Q2 24 | $527.8M | $64.8M | ||
| Q1 24 | $582.0M | $67.0M |
| Q4 25 | — | $75.7M | ||
| Q3 25 | $661.9M | $74.7M | ||
| Q2 25 | $721.0M | $78.7M | ||
| Q1 25 | $746.3M | $85.3M | ||
| Q4 24 | — | $86.2M | ||
| Q3 24 | $827.5M | $87.6M | ||
| Q2 24 | $853.6M | $90.9M | ||
| Q1 24 | $901.4M | $94.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $4.0M |
| Free Cash FlowOCF − Capex | $-72.3M | $3.9M |
| FCF MarginFCF / Revenue | -341.2% | 20.5% |
| Capex IntensityCapex / Revenue | 20.8% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.0M | ||
| Q3 25 | $-67.9M | $4.4M | ||
| Q2 25 | $-72.8M | $2.8M | ||
| Q1 25 | $-75.6M | $1.9M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | $-76.7M | $2.3M | ||
| Q2 24 | $-51.1M | $2.2M | ||
| Q1 24 | $-40.5M | $666.0K |
| Q4 25 | — | $3.9M | ||
| Q3 25 | $-72.3M | — | ||
| Q2 25 | $-80.1M | — | ||
| Q1 25 | $-83.8M | $1.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-86.3M | — | ||
| Q2 24 | $-51.9M | — | ||
| Q1 24 | $-41.0M | — |
| Q4 25 | — | 20.5% | ||
| Q3 25 | -341.2% | — | ||
| Q2 25 | -382.6% | — | ||
| Q1 25 | -933.1% | 12.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -406.8% | — |
| Q4 25 | — | 0.1% | ||
| Q3 25 | 20.8% | 0.0% | ||
| Q2 25 | 34.8% | 0.0% | ||
| Q1 25 | 91.8% | 0.5% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | 5.3% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.56× | ||
| Q1 25 | — | 6.03× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
